Genky DrugStores Co Ltd
TSE:9267
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2 527.1895
3 845
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Genky DrugStores Co Ltd
Income from Continuing Operations
Genky DrugStores Co Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Genky DrugStores Co Ltd
TSE:9267
|
Income from Continuing Operations
ÂĄ6.5B
|
CAGR 3-Years
11%
|
CAGR 5-Years
23%
|
CAGR 10-Years
16%
|
||
Sundrug Co Ltd
TSE:9989
|
Income from Continuing Operations
ÂĄ29.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
||
Tsuruha Holdings Inc
TSE:3391
|
Income from Continuing Operations
ÂĄ27.5B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
6%
|
||
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Income from Continuing Operations
ÂĄ24.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Income from Continuing Operations
ÂĄ52.3B
|
CAGR 3-Years
32%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
||
Cosmos Pharmaceutical Corp
TSE:3349
|
Income from Continuing Operations
ÂĄ26.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
Genky DrugStores Co Ltd
Glance View
Genky DrugStores Co., Ltd. operates as a holding company which provides the management of its group companies that is engaged in the management of drug stores. The company is headquartered in Sakai-Shi, Fukui-Ken and currently employs 1,501 full-time employees. The company went IPO on 2017-12-21. The firm is mainly engaged in the retail of medicines, cosmetics, miscellaneous goods, foods and others.
See Also
What is Genky DrugStores Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
6.5B
JPY
Based on the financial report for Sep 20, 2024, Genky DrugStores Co Ltd's Income from Continuing Operations amounts to 6.5B JPY.
What is Genky DrugStores Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
16%
Over the last year, the Income from Continuing Operations growth was 27%. The average annual Income from Continuing Operations growth rates for Genky DrugStores Co Ltd have been 11% over the past three years , 23% over the past five years , and 16% over the past ten years .